209 related articles for article (PubMed ID: 26870821)
21. Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children.
Varon E; Cohen R; Béchet S; Doit C; Levy C
Vaccine; 2015 Nov; 33(46):6178-85. PubMed ID: 26476365
[TBL] [Abstract][Full Text] [Related]
22. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
[TBL] [Abstract][Full Text] [Related]
23. Genetic variation of innate immune response genes in invasive pneumococcal and meningococcal disease applied to the pathogenesis of meningitis.
Sanders MS; van Well GT; Ouburg S; Morré SA; van Furth AM
Genes Immun; 2011 Jul; 12(5):321-34. PubMed ID: 21471994
[TBL] [Abstract][Full Text] [Related]
24. Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo.
Traore Y; Tameklo TA; Njanpop-Lafourcade BM; Lourd M; Yaro S; Niamba D; Drabo A; Mueller JE; Koeck JL; Gessner BD
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S181-9. PubMed ID: 19191614
[TBL] [Abstract][Full Text] [Related]
25. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel.
Ben-Shimol S; Greenberg D; Givon-Lavi N; Elias N; Glikman D; Rubinstein U; Dagan R;
Vaccine; 2012 Oct; 30(46):6600-7. PubMed ID: 22939907
[TBL] [Abstract][Full Text] [Related]
26. Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria.
Rendi-Wagner P; Georgopoulos A; Kundi M; Mutz I; Mattauch M; Nowak J; Mikolasek A; Vecsei A; Kollaritsch H
J Antimicrob Chemother; 2004 May; 53(5):826-31. PubMed ID: 15073163
[TBL] [Abstract][Full Text] [Related]
27. Genetic variation and cerebrospinal fluid levels of mannose binding lectin in pneumococcal meningitis patients.
Brouwer MC; Baas F; van der Ende A; van de Beek D
PLoS One; 2013; 8(5):e65151. PubMed ID: 23741476
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso.
Yaro S; Lourd M; Traoré Y; Njanpop-Lafourcade BM; Sawadogo A; Sangare L; Hien A; Ouedraogo MS; Sanou O; Parent du Châtelet I; Koeck JL; Gessner BD
Clin Infect Dis; 2006 Sep; 43(6):693-700. PubMed ID: 16912941
[TBL] [Abstract][Full Text] [Related]
29. Single nucleotide polymorphisms in TLR9 are highly associated with susceptibility to bacterial meningitis in children.
Sanders MS; van Well GT; Ouburg S; Lundberg PS; van Furth AM; Morré SA
Clin Infect Dis; 2011 Feb; 52(4):475-80. PubMed ID: 21258099
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
Shibl AM; Memish ZA; Al-Kattan KM
Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
[TBL] [Abstract][Full Text] [Related]
31. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study.
Stensballe LG; Hjuler T; Andersen A; Kaltoft M; Ravn H; Aaby P; Simoes EA
Clin Infect Dis; 2008 Apr; 46(8):1165-71. PubMed ID: 18444851
[TBL] [Abstract][Full Text] [Related]
32. Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis.
Lees JA; Ferwerda B; Kremer PHC; Wheeler NE; Serón MV; Croucher NJ; Gladstone RA; Bootsma HJ; Rots NY; Wijmega-Monsuur AJ; Sanders EAM; Trzciński K; Wyllie AL; Zwinderman AH; van den Berg LH; van Rheenen W; Veldink JH; Harboe ZB; Lundbo LF; de Groot LCPGM; van Schoor NM; van der Velde N; Ängquist LH; Sørensen TIA; Nohr EA; Mentzer AJ; Mills TC; Knight JC; du Plessis M; Nzenze S; Weiser JN; Parkhill J; Madhi S; Benfield T; von Gottberg A; van der Ende A; Brouwer MC; Barrett JC; Bentley SD; van de Beek D
Nat Commun; 2019 May; 10(1):2176. PubMed ID: 31092817
[TBL] [Abstract][Full Text] [Related]
33. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
[TBL] [Abstract][Full Text] [Related]
34. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome.
Jansen AG; Rodenburg GD; van der Ende A; van Alphen L; Veenhoven RH; Spanjaard L; Sanders EA; Hak E
Clin Infect Dis; 2009 Jul; 49(2):e23-9. PubMed ID: 19522653
[TBL] [Abstract][Full Text] [Related]
35. Genetic susceptibility to severe infection in families with invasive pneumococcal disease.
Hjuler T; Poulsen G; Wohlfahrt J; Kaltoft M; Biggar RJ; Melbye M
Am J Epidemiol; 2008 Apr; 167(7):814-9. PubMed ID: 18227098
[TBL] [Abstract][Full Text] [Related]
36. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.
Ispahani P; Slack RC; Donald FE; Weston VC; Rutter N
Arch Dis Child; 2004 Aug; 89(8):757-62. PubMed ID: 15269078
[TBL] [Abstract][Full Text] [Related]
37. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
Motlova J; Benes C; Kriz P
Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.
Andrade AL; Minamisava R; Policena G; Cristo EB; Domingues CM; de Cunto Brandileone MC; Almeida SC; Toscano CM; Bierrenbach AL
Hum Vaccin Immunother; 2016; 12(2):285-92. PubMed ID: 26905679
[TBL] [Abstract][Full Text] [Related]
39. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.
van Hoek AJ; Andrews N; Waight PA; Stowe J; Gates P; George R; Miller E
J Infect; 2012 Jul; 65(1):17-24. PubMed ID: 22394683
[TBL] [Abstract][Full Text] [Related]
40. Comparison of cytokine gene polymorphisms among Greek patients with invasive meningococcal disease or viral meningitis.
Titmarsh CJ; Moscovis SM; Hall S; Tzanakaki G; Kesanopoulos K; Xirogianni A; Scott RJ; Blackwell CC
J Med Microbiol; 2013 May; 62(Pt 5):694-700. PubMed ID: 23378564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
